|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
ATE384529T1
(de)
*
|
2003-03-28 |
2008-02-15 |
Nycomed Gmbh |
Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen
|
|
BRPI0409492A
(pt)
*
|
2003-04-18 |
2006-05-02 |
Pharmacia & Up John Company Ll |
terapias de combinação
|
|
WO2004103407A2
(en)
*
|
2003-05-22 |
2004-12-02 |
Altana Pharma Ag |
Composition comprising a pde4 inhibitor and a pde5 inhibitor
|
|
EP1651222A1
(en)
*
|
2003-07-29 |
2006-05-03 |
Boehringer Ingelheim International Gmbh |
Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders
|
|
EP1504756A1
(en)
*
|
2003-08-06 |
2005-02-09 |
Kyowa Hakko Kogyo Co., Ltd |
Medicament compositions comprising a heterocyclic compound and an anticholinergic
|
|
PL1713471T3
(pl)
*
|
2004-02-06 |
2012-06-29 |
Meda Pharma Gmbh & Co Kg |
Kombinacja środków antycholinergicznych i inhibitorów fosfodiesterazy typu 4 do leczenia chorób oddechowych
|
|
RU2006132043A
(ru)
*
|
2004-02-06 |
2008-03-20 |
МЕДА Фарма ГмбХ унд Ко.КГ (DE) |
Комбинация и фармацевтический препарат для лечения ринита
|
|
AU2005210085B2
(en)
|
2004-02-06 |
2010-06-24 |
Meda Pharma Gmbh & Co. Kg |
The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD
|
|
US7507745B2
(en)
|
2004-02-20 |
2009-03-24 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
|
|
JP2007523117A
(ja)
*
|
2004-02-20 |
2007-08-16 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗コリン作用薬及びｐｅｇｓｕｎｅｒｃｅｐｔを基にした新規な医薬組成物
|
|
NZ551669A
(en)
*
|
2004-05-31 |
2010-07-30 |
Almirall Lab |
Combinations comprising antimuscarinic agents and PDE4 inhibitors
|
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
US20060079544A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Boehringer Ingelheim International Gmbh |
Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
|
|
MX2007011273A
(es)
|
2005-03-16 |
2007-11-08 |
Meda Pharma Gmbh & Co Kg |
La combinacion de anticolinergicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias.
|
|
US8012971B2
(en)
*
|
2005-04-28 |
2011-09-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
Therapeutic agent for chronic obstructive pulmonary disease
|
|
DE102005035112A1
(de)
*
|
2005-07-27 |
2007-02-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
|
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス，インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
|
US7985756B2
(en)
|
2005-10-21 |
2011-07-26 |
Braincells Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
WO2007053596A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
WO2007071313A2
(en)
|
2005-12-21 |
2007-06-28 |
Meda Pharma Gmbh & Co Kg |
Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
|
EP1905440A1
(de)
*
|
2006-09-06 |
2008-04-02 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verwendung einer pharmazeutischen Zusammensetzung enthaltend ein Anticholinergikum zur Abtötung von Mikroorganismen und zur Behandlung von Atemwegsinfektionen
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
|
EA021019B1
(ru)
|
2009-06-18 |
2015-03-31 |
Концерт Фармасьютикалс, Инк. |
Дейтерированные производные изоиндолин-1,3-диона
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
EP2804603A1
(en)
|
2012-01-10 |
2014-11-26 |
President and Fellows of Harvard College |
Beta-cell replication promoting compounds and methods of their use
|